Updated shots to shield against COVID-19 infection were approved by the U.S. Food and Drug Administration on Thursday.

This year’s approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 11.

The latest shots from Moderna and Pfizer will now target a variant of the Omicron strain of the virus called KP.2, the FDA said in a statement.

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=MTRmNjRiZTQtYjBjZC00N2M1LTg5ZDgtYzFiZTAyZjE4Y2U3&client=Nw%3D%3D&section=undefined